open-burger-menu
Search Icon
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
📈 NEW Report: Abortions, Tax Funding UP at Planned Parenthood >>
Search Icon
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

close-panel
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Research Type:

Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research

Sort 1464 results by:

Filter results further
Filter Applied. Clear All

Latest Posts

October 6, 2026 A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review October 6, 2026 Inside The Government Decision That Opened Up Abortion Pill Floodgates Inside The Government Decision That Opened Up Abortion Pill Floodgates October 6, 2026 Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone
Research Type
Publication Type
By State
See All
By Author
See All
Reset All Filters

Did You Know ?

Did You Know ?

In the fourth week, the embryonic heart starts beating. The neural tube, which becomes the brain and spinal cord, forms. At this point, a woman has likely only been aware of her pregnancy for one week.

Did You Know ?

In the seventh week after conception, networks of neurons produce brain waves that have been recorded as early as 6 ½ weeks after conception. The embryo spontaneously moves his arms, hands, and legs, and may even hiccup. The embryo’s heart now has all four chambers.

Did You Know ?

By the seventeenth and eighteenth week after gestation, the fetus shows a clear response to pain in multiple studies, and at least one brain pathway is mature enough to create a perception of pain. The fetus also practices breathing, crying, and breastfeeding in the womb. The fetal heart has beat over 20 million times and circulates about 55 quarts of blood per day.

Did You Know ?

In the eighth month of pregnancy the fetal brain is ready to learn! At 32 weeks after conception, neurons are creating 40,000 new connections, called synapses, every second! With repeated exposures, the fetus can learn flavors, nursery rhymes, songs, and even words that she will recognize after birth!

A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review
Latest Research / Life & the Law

A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review

This paper critically analyzes the FDA's 2021 REMS Review leading to the removal of the in-person dispensing requirement for mifepristone.

Zachary Sluzala,… Ingrid Skop,…
October 6, 2026
Inside The Government Decision That Opened Up Abortion Pill Floodgates
Latest Research / Abortion Drugs

Inside The Government Decision That Opened Up Abortion Pill Floodgates

The decision "fell well short" of the FDA's standards.

charlotte-lozier-institute Charlotte Lozier Institute
October 6, 2026
Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone
Latest Research / Life & the Law

Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone

This paper critically analyzes the FDA's 2021 literature review that served as the basis for its controversial decision to remove…

Ingrid Skop,…
October 6, 2026
Peer-Reviewed Article: FDA Lacked Evidence to Drop In-Person Abortion Drug Requirement
Latest Research / General

Peer-Reviewed Article: FDA Lacked Evidence to Drop In-Person Abortion Drug Requirement

A new peer-reviewed article on the Food and Drug Administration’s (FDA) 2021 complete review of mifepristone’s Risk Evaluation and Mitigation…

charlotte-lozier-institute Charlotte Lozier Institute
October 6, 2026
Abortion Reporting: Kentucky (2025)
Latest Research / Maternal & Public Health

Abortion Reporting: Kentucky (2025)

In 2025, five brick-and-mortar abortions were reported in Kentucky by the state’s Cabinet for Health and Family Services. The data…

Elyse Gaitan Mia Steupert,…
October 5, 2026
Fetal Development

Unique from Day One: Pro-life is Pro-science

Science displays majesty in Alexander Tsiaras’ “From Conception to Birth Visualization” shared during his 2010 TED Talk.  Through magnificent artistry and scientific genius, Tsiaras’ visualization embodies this year’s March for Life theme - Unique from Day One: Pro-life is Pro-science.

Moira Gaul, M.P.H.
January 18, 2019
Maternal & Public Health

Abortion Reporting: New York (2016)

As New York imposes additional abortion coverage, improved reporting is particularly necessary to demonstrate the impact of new rules and regulations.  

Tessa Cox
January 10, 2019
Written Testimony of David A. Prentice, Ph.D., in Support of Ethical Alternatives to Aborted Fetal Tissue Research
Fetal Tissue, Stem Cells & Bioethics

Written Testimony of David A. Prentice, Ph.D., in Support of Ethical Alternatives to Aborted Fetal Tissue Research

On Thursday, December 13, 2018, the U.S. House of Representatives subcommittee on Healthcare, Benefits, and Administrative Rules and Government Operations for the Committee on Oversight and Government Reform held a hearing on “Exploring Alternatives to Fetal Tissue Research.” 

David Prentice, Ph.D.
January 9, 2019
2018: A Year of Pro-life Triumphs and Challenges
Life & the Law

2018: A Year of Pro-life Triumphs and Challenges

2018 has been a year of triumphs and challenges for those of us in the pro-life movement. As we seek greater recognition for the inalienable right to life of the unborn, let us look back on some of the more memorable events from 2018 for the pro-life movement.

charlotte-lozier-institute Charlotte Lozier Institute
January 8, 2019
Reviving the Equal Rights Amendment to Keep Abortion Legal
Life & the Law

Reviving the Equal Rights Amendment to Keep Abortion Legal

Many Americans think of the Equal Rights Amendment (ERA) as an issue from another era in American history. And so it is – a 22-word amendment to the Constitution first proposed in 1972, fiercely debated, but failing of ratification by the deadlines Congress established, then extended by majority vote, for it. But for some advocates, including prominent politicians, the ERA is very much alive and will become a part of our Constitution, they think, if just three more states “agree” to it, instead of the 38 normally required for an amendment to become part of the Constitution. And one of those advocates is on the verge of taking a powerful post where he might make all the difference.

charlotte-lozier-institute Charlotte Lozier Institute
December 22, 2018
Written Testimony of Tara Sander Lee, Ph.D., in Support of Ethical Alternatives to Aborted Fetal Tissue Research
Fetal Tissue, Stem Cells & Bioethics

Written Testimony of Tara Sander Lee, Ph.D., in Support of Ethical Alternatives to Aborted Fetal Tissue Research

On Thursday, December 13, 2018, the U.S. House of Representatives subcommittee on Healthcare, Benefits, and Administrative Rules and Government Operations for the Committee on Oversight and Government Reform held a hearing on "Exploring Alternatives to Fetal Tissue Research." The hearing was called as the U.S. Department of Health and Human Services re-evaluates funding for research using tissue from aborted babies. Charlotte Lozier Institute Associate Scholar Tara Sander Lee, Ph.D., submitted the following written testimony in support of using ethical alternatives to aborted fetal tissue research.

Tara Sander Lee,…
December 20, 2018
Maternal & Public Health

Abortion Reporting: New York City (2016)

New York City has included abortion data in its vital statistics report since 1962. The city’s vital statistics report for 2016 reveals that abortion in the Big Apple is continuing to decline, although the abortion rate is still high compared to the rest of the nation.

Tessa Cox
December 19, 2018
Maternal & Public Health

Abortion Reporting: New Jersey (2016)

New Jersey’s 2016 abortion report shows that abortions in the state have increased. However, abortion reporting in the state is not mandatory for all abortion providers, meaning that abortions in the Garden State are underreported. New Jersey does not publish its abortion report online but made it available to the Charlotte Lozier Institute upon request.

Tessa Cox
December 19, 2018

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image